Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic

por Rios-Hoyo, Alejandro, Arriola, Edurne
Publicado 2023

Acquired Mechanisms of Resistance to Osimertinib—The Next Challenge

por Ríos-Hoyo, Alejandro, Moliner, Laura, Arriola, Edurne
Publicado 2022

EGFR-Mutant Lung Adenocarcinoma Mimicking a Pneumonia

por Taus, Álvaro, Zuccarino, Flavio, Trampal, Carlos, Arriola, Edurne
Publicado 2012

Multiple Brain Pseudoprogression in a Patient With NSCLC Treated With Pembrolizumab

por Moliner, Laura, Capellades, Jaume, Taus, Álvaro, Arriola, Edurne
Publicado 2020

Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitis

por Arriola, Edurne, Wheater, Matthew, Lopez, Maria Antonette, Thomas, Gareth, Ottensmeier, Christian
Publicado 2016

Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma

por Karydis, Ioannis, Chan, Pui Ying, Wheater, Matthew, Arriola, Edurne, Szlosarek, Peter W., Ottensmeier, Christian H.
Publicado 2016

MET Inhibitors in Small Cell Lung Cancer: From the Bench to the Bedside

por Hardy-Werbin, Max, del Rey-Vergara, Raúl, Galindo-Campos, Miguel Alejandro, Moliner, Laura, Arriola, Edurne
Publicado 2019

Prognostic Value of Clinical Staging According to TNM in Patients With SCLC: A Real-World Surveillance Epidemiology and End-Results Database Analysis

por Arriola, Edurne, Trigo, José Manuel, Sánchez-Gastaldo, Amparo, Navarro, Alejandro, Perez, Coral, Crama, Leonardo, Ponce-Aix, Santiago
Publicado 2021

Healthcare resource utilization in advanced non-small-cell lung cancer: post hoc analysis of the randomized phase 3 REVEL study

por Garon, Edward B., Winfree, Katherine B., Molife, Cliff, Cui, Zhanglin Lin, Arriola, Edurne, Levy, Benjamin, Mekhail, Tarek, Pérol, Maurice
Publicado 2020

Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)

por García-Campelo, Rosario, Sullivan, Ivana, Arriola, Edurne, Insa, Amelia, Juan Vidal, Oscar, Cruz-Castellanos, Patricia, Morán, Teresa, Reguart, Noemí, Zugazagoitia, Jon, Dómine, Manuel
Publicado 2023

SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)

por García-Campelo, Rosario, Sullivan, Ivana, Arriola, Edurne, Insa, Amelia, Juan Vidal, Oscar, Cruz-Castellanos, Patricia, Morán, Teresa, Reguart, Noemí, Zugazagoitia, Jon, Dómine, Manuel
Publicado 2023

EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma

por Chalela, Roberto, Bellosillo, Beatriz, Curull, Víctor, Longarón, Raquel, Pascual-Guardia, Sergi, Badenes-Bonet, Diana, Arriola, Edurne, Sánchez-Font, Albert, Pijuan, Lara, Gea, Joaquim
Publicado 2019

Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-An...

por Arriola, Edurne, González-Cao, María, Domine, Manuel, De Castro, Javier, Cobo, Manuel, Bernabé, Reyes, Navarro, Alejandro, Sullivan, Ivana, Trigo, José Manuel, Mosquera, Joaquín, Crama, Leonardo, Isla, Dolores
Publicado 2022

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)

por Casadevall, David, Gimeno, Javier, Clavé, Sergi, Taus, Álvaro, Pijuan, Lara, Arumí, Miriam, Lorenzo, Marta, Menéndez, Silvia, Cañadas, Israel, Albanell, Joan, Serrano, Sergio, Espinet, Blanca, Salido, Marta, Arriola, Edurne
Publicado 2015

Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC

por Rocha, Pedro, Ramal, Didac, Ripoll, Enric, Moliner, Laura, Corbera, Alex, Hardy-Werbin, Max, Orrillo, Mayra, Taus, Álvaro, Zuccarino, Flavio, Gibert, Joan, Perera-Bel, Júlia, Casadevall, David, Arriola, Edurne
Publicado 2020

CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung Cancer

por Olingy, Claire, Alimadadi, Ahmad, Araujo, Daniel J., Barry, David, Gutierrez, Norma A., Werbin, Max Hardy, Arriola, Edurne, Patel, Sandip Pravin, Ottensmeier, Christian H., Dinh, Huy Q., Hedrick, Catherine C.
Publicado 2022

High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients

por Cañadas, Israel, Taus, Álvaro, González, Iria, Villanueva, Xavier, Gimeno, Javier, Pijuan, Lara, Dómine, Manuel, Sánchez-Font, Albert, Vollmer, Ivan, Menéndez, Silvia, Arpí, Oriol, Mojal, Sergi, Rojo, Federico, Rovira, Ana, Albanell, Joan, Arriola, Edurne
Publicado 2014

ROS1 copy number alterations are frequent in non-small cell lung cancer

por Clavé, Sergi, Gimeno, Javier, Muñoz-Mármol, Ana M., Vidal, Joana, Reguart, Noemí, Carcereny, Enric, Pijuan, Lara, Menéndez, Sílvia, Taus, Álvaro, Mate, José Luís, Serrano, Sergio, Albanell, Joan, Espinet, Blanca, Arriola, Edurne, Salido, Marta
Publicado 2016

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

por Arriola, Edurne, Wheater, Matthew, Galea, Ian, Cross, Nadia, Maishman, Tom, Hamid, Debbie, Stanton, Louise, Cave, Judith, Geldart, Tom, Mulatero, Clive, Potter, Vannessa, Danson, Sarah, Woll, Pennella J., Griffiths, Richard, Nolan, Luke, Ottensmeier, Christian
Publicado 2016

PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis

por García Campelo, María Rosario, Arriola, Edurne, Campos Balea, Begoña, López-Brea, Marta, Fuentes-Pradera, José, de Castro Carpeno, Javier, Aguado, Carlos, Pérez Parente, Diego, de Oro Pulido, Fidel, Ruiz-Gracia, Pedro, Rodríguez-Abreu, Delvys
Publicado 2021